clinical validation of cambridge neuropsychological test automated battery in a norwegian epilepsy population临床验证的剑桥大学神经心理学测试自动化电池在挪威癫痫人群.pdfVIP

Journal of Behavioral and Brain Science, 2012, 2, 108-116 /10.4236/jbbs.2012.21013 Published Online February 2012 (http://www.SciRP.org/journal/jbbs) Clinical Validation of Cambridge Neuropsychological Test Automated Battery in a Norwegian Epilepsy Population Johan Torgersen1,2, Hans Flaatten1,2, Bernt A. Engelsen3,4, Arne Gramstad3,5 1Department of Anaesthesiology and Intensive Care Medicine, Haukeland University Hospital, Bergen, Norway 2Department of Surgical Sciences, Section for Anaesthesiology and Intensive Care, University of Bergen, Bergen, Norway 3Department of Neurology, Haukeland University Hospital, Bergen, Norway 4Department of Clinical Medicine, Section for Neurology, University of Bergen, Bergen, Norway 5Faculty of Psychology, University of Bergen, Bergen, Norway Email: johan.torgersen@legeforeningen.no Received July 13, 2011; revised October 13, 2011; accepted November 11, 2011 ABSTRACT Introduction: Semi-automatic neuropsychological testing has gained a position both in clinical use and in research. Comparison studies with traditional neuropsychological tests are sparse and the role of such semi-automated testing is debated. To integrate semi-automated neuropsychological testing in the established clinical setting the tests must be validated in the patient groups addressed. The aim of this study was to validate Cambridge Neuropsychological Tests Automated Battery (CANTAB) in patients with epilepsy. Material and Methods: Patients scheduled for traditional neuropsychological testing with Category test (CT), Trail Making Test part B (TMT-B), WAIS-III and WMS-R were also asked to complete the CANTAB battery. Our hypothesis was that memory te